Medical progress - Head and neck cancer

[81] p63 is a p53 homologue required for limb and epidermal morphogenesis [J]. NATURE, 1999, 398 (6729) : 708 - 713

[82] Munro J, 1999, CANCER RES, V59, P2516

[83] Microsatellite alterations in serum DNA of head and neck cancer patients [J]. NATURE MEDICINE, 1996, 2 (09) : 1035 - 1037

[84] NAWROZ H, 1994, CANCER RES, V54, P1152

[85] A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma, results of the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85 [J]. RADIOTHERAPY AND ONCOLOGY, 1998, 46 (02) : 135 - 146

[86] Frequent inactivation of p16(INK4a) in oral premalignant lesions [J]. ONCOGENE, 1997, 14 (15) : 1799 - 1803

[87] Partridge M, 2000, CLIN CANCER RES, V6, P2718

[88] Partridge M, 2000, CANCER RES, V60, P3893

[89] Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (09) : 1674 - 1681

[90] Peters L. J., 1999, International Journal of Radiation Oncology Biology Physics, V45, P148, DOI 10.1016/S0360-3016(99)90026-3

[81] p63 is a p53 homologue required for limb and epidermal morphogenesis [J]. NATURE, 1999, 398 (6729) : 708 - 713

[82] Munro J, 1999, CANCER RES, V59, P2516

[83] Microsatellite alterations in serum DNA of head and neck cancer patients [J]. NATURE MEDICINE, 1996, 2 (09) : 1035 - 1037

[84] NAWROZ H, 1994, CANCER RES, V54, P1152

[85] A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma, results of the Danish Head and Neck Cancer Study (DAHANCA) protocol 5-85 [J]. RADIOTHERAPY AND ONCOLOGY, 1998, 46 (02) : 135 - 146

[86] Frequent inactivation of p16(INK4a) in oral premalignant lesions [J]. ONCOGENE, 1997, 14 (15) : 1799 - 1803

[87] Partridge M, 2000, CLIN CANCER RES, V6, P2718

[88] Partridge M, 2000, CANCER RES, V60, P3893

[89] Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (09) : 1674 - 1681

[90] Peters L. J., 1999, International Journal of Radiation Oncology Biology Physics, V45, P148, DOI 10.1016/S0360-3016(99)90026-3